CompletedNo phase
"Critical State" Early Warning Score After CHD Surgery and Rapid Response Team
Key facts
- Who runs it
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 4,115 people enrolled
- Started
- 1 Jan 2021
- Ended
- 1 Jul 2024
- Type of study
- Observational
- Record updated
- 29 August 2024
Who can take part
- Age
- 28 days to 14 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- pediatrics admitted to ICU
Who cannot take part
- surgery without cardiopulmonary bypass
- using extra-corporeal circulation during surgery
- Delayed chest closing during surgery
- neonatal
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
By establishing a warning scoring tool for the early \"critical state\" after congenital heart disease surgery, the multidisciplinary rapid response team is proactively activated, forming an integrated treatment model of early warning-team decision-making-organ assistance.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Study on Establishing a "Critical State" Early Warning Score After Congenital Heart Disease Surgery and an Integrated Treatment Model of a Multidisciplinary Rapid Response Team
- Record updated
- 29 August 2024